Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cutler

Showing results (441-450 of 543) with videos related to

Pageof 55
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Blood|April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood graftsClaudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Microbiology Resource Announcements|September 19, 2022
Annotation of the Complete Genome Sequences of Bacteriophages Sara and BirdfeederBenjamin M Adams, Joseph B Adams, Reganne L Brewster, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcomePhilippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II TrialJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2015
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationMukta Arora, Corey S Cutler, Madan H Jagasia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host diseaseCaron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Pageof 55

Showing results (441-450 of 543) with videos related to

Sort By:
Pageof 55
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Bone Marrow Transplantation|January 25, 2011
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphomaK E Abou-Nassar, K E Stevenson, J H Antin, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Blood|April 30, 2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood graftsClaudio G Brunstein, Ephraim J Fuchs, Shelly L Carter, et al.
Microbiology Resource Announcements|September 19, 2022
Annotation of the Complete Genome Sequences of Bacteriophages Sara and BirdfeederBenjamin M Adams, Joseph B Adams, Reganne L Brewster, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcomePhilippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II TrialJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2015
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationMukta Arora, Corey S Cutler, Madan H Jagasia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host diseaseCaron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Pageof 55